Surveillance for hepatocellular carcinoma in patients with cirrhosis

Clinical Gastroenterology and Hepatology

Volumn 10, Issue 1, 2012, Pages 16-21

  Yang, Ju Dong ^a   Kim, W Ray ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; ANTINEOPLASTIC AGENT; CONTRAST MEDIUM; ENTECAVIR; FUROSEMIDE; HEPATITIS B SURFACE ANTIGEN; HEPATITIS E ANTIGEN; PROPRANOLOL; SPIRONOLACTONE; VIRUS DNA;

ABDOMINAL SWELLING; ADULT; ANTIVIRAL THERAPY; ARTICLE; ASCITES; CANCER EPIDEMIOLOGY; CANCER PATIENT; CHEMOEMBOLIZATION; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIURETIC THERAPY; ECHOGRAPHY; ESOPHAGOGASTRODUODENOSCOPY; ESOPHAGUS VARICES; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATOGRAPHY; HEPATOSPLENOMEGALY; HUMAN; LEG EDEMA; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER NODULE; LIVER TRANSPLANTATION; MALE; NONALCOHOLIC FATTY LIVER; NUCLEAR MAGNETIC RESONANCE IMAGING; PORTAL HYPERTENSION; PRACTICE GUIDELINE; PRIMARY BILIARY CIRRHOSIS; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL;

EID: 84860389466     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2011.06.004     Document Type: Article

References (10)

1. J. Bruix S.M. Aasld AASLD practice guideline, management of hepatocellular carcinoma: an update http://www.aasld.org/practiceguidelines/Documents/Bookmarked%20Practice%20Guidelines/HCCUpdate2010.pdf Accessed August 02, 2010
2. J. Bruix M. Sherman Management of hepatocellular carcinoma Hepatology 42 2005 1208 1236
3. J. Bruix M. Sherman J.M. Llovet Clinical management of hepatocellular carcinoma: conclusions of the Barcelona-2000 EASL Conference—European Association for the Study of the Liver J Hepatol 35 2001 421 430
4. B.H. Zhang B.H. Yang Z.Y. Tang Randomized controlled trial of screening for hepatocellular carcinoma J Cancer Res Clin Oncol 130 2004 417 422
5. J.A. Davila R.O. Morgan P.A. Richardson Use of surveillance for hepatocellular carcinoma among patients with cirrhosis in the United States Hepatology 52 2010 132 141
6. J.A. Marrero Z. Feng Y. Wang Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma Gastroenterology 137 2009 110 118
7. A.S. Lok R.K. Sterling J.E. Everhart Des-gamma-carboxy prothrombin and alpha-fetoprotein as biomarkers for the early detection of hepatocellular carcinoma Gastroenterology 138 2010 493 502
8. V. Santi F. Trevisani A. Gramenzi Semiannual surveillance is superior to annual surveillance for the detection of early hepatocellular carcinoma and patient survival J Hepatol 53 2010 291 297
9. J.G. Chen D.M. Parkin Q.G. Chen Screening for liver cancer: results of a randomised controlled trial in Qidong, China J Med Screen 10 2003 204 209
10. J.A. Davila L. Henderson J.R. Kramer Utilization of surveillance for hepatocellular carcinoma among hepatitis C virus-infected veterans in the United States Ann Intern Med 154 2011 85 93